Published in Diabet Med on September 01, 2011
Non-invasive detection of microvascular changes in a paediatric and adolescent population with type 1 diabetes: a pilot cross-sectional study. BMC Endocr Disord (2013) 0.79
Nailfold capillary abnormalities are associated with type 2 diabetes progression and correlated with peripheral neuropathy. Medicine (Baltimore) (2016) 0.75
Assessment of the Relationship between Diabetic Retinopathy and Nailfold Capillaries in Type 2 Diabetics with a Noninvasive Method: Nailfold Videocapillaroscopy. J Diabetes Res (2016) 0.75
Compliance with dietary guidelines affects capillary recruitment in healthy middle-aged men and women. Eur J Nutr (2016) 0.75
Nailfold capillary morphology in exfoliation syndrome. Eye (Lond) (2017) 0.75
The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med (2006) 1.77
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab (2004) 1.68
No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group. Diabetologia (2000) 1.48
Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters. Rev Rhum Engl Ed (1996) 1.38
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis (2010) 1.22
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19
Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population. Int J Obes (Lond) (2007) 1.16
Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis Rheum (2011) 1.06
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis (2011) 1.05
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis (2010) 1.05
Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study. Clin Exp Rheumatol (1996) 0.99
Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70. J Biol Chem (2000) 0.99
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. Arthritis Rheum (2011) 0.98
Currently used non-specific extracellular MR contrast media. Eur Radiol (2003) 0.97
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. Arthritis Rheum (2011) 0.96
The immune response to influenza vaccination in diabetic patients. Diabetologia (1986) 0.95
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. Arthritis Rheum (2010) 0.94
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation. Clin Exp Immunol (2015) 0.90
Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Immunotherapy Diabetes. Metabolism (1998) 0.90
The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation. J Endocrinol (2006) 0.88
Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol (2006) 0.88
Relationship of interleukin-12 and interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus. Clin Rheumatol (2003) 0.87
Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM. J Endocrinol (1999) 0.86
Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis. Rev Rhum Engl Ed (1997) 0.85
Autonomic dysfunction and neuropeptide Y in fibromyalgia. Clin Exp Rheumatol (2010) 0.85
Hepatitis C virus infection of salivary gland epithelial cells. Lack of evidence. J Hepatol (1997) 0.85
Co-occurrence of psoriatic arthritis with collagenous colitis: clinicopathologic findings of a case. Clin Rheumatol (2002) 0.85
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI). Diabetes Metab Res Rev (1999) 0.84
Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis. Rev Rhum Engl Ed (1998) 0.84
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study. Ann Rheum Dis (2008) 0.84
Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis. Clin Exp Rheumatol (2007) 0.84
Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile. Clin Exp Rheumatol (2002) 0.84
Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis. Clin Rheumatol (1995) 0.83
Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis. Ann Rheum Dis (2002) 0.83
More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? Clin Exp Rheumatol (2009) 0.82
Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters. Clin Exp Rheumatol (1997) 0.82
Correlations between peripheral and axial radiological changes in patients with psoriatic polyarthritis. Rev Rhum Engl Ed (1996) 0.82
Ultrasound transmission velocity of the proximal phalanxes of the non-dominant hand in the study of osteoporosis. Clin Rheumatol (1997) 0.81
Adhesion molecule expression in the synovial membrane of psoriatic arthritis. Ann Rheum Dis (2002) 0.81
Combined phacoemulsification and deep sclerectomy vs phacoemulsification and trabeculectomy. Acta Ophthalmol Scand Suppl (2000) 0.80
Sternoclavicular joint disease in psoriatic arthritis. Ann Rheum Dis (1992) 0.80
A case of relapsing polychondritis: pathogenetic considerations. Clin Exp Rheumatol (1988) 0.80
Inhaled insulin in type 1 diabetes. Lancet (2001) 0.79
Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group. Diabet Med (1994) 0.79
Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis. Clin Exp Rheumatol (2007) 0.79
Unusual shift from IgE-mediated milk allergy to food protein-induced enterocolitis syndrome. Eur Ann Allergy Clin Immunol (2013) 0.79
Phacoemulsification and intraocular lens implant in eyes with primary angle-closure glaucoma: our experience. Acta Ophthalmol Scand Suppl (2002) 0.79
Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin. Diabetologia (2004) 0.79
Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II Study. Diabetes Care (1994) 0.79
Comparison of ultrasound transmission velocity with computed metacarpal radiogrammetry and dual-photon absorptiometry. Eur Radiol (1996) 0.79
[Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis]. Reumatismo (2006) 0.78
One year treatment with low dose methotrexate in rheumatoid arthritis: effect on class specific rheumatoid factors. Clin Rheumatol (1993) 0.78
The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma. Eur J Ophthalmol (2005) 0.78
Anti-endothelial cell antibodies in rheumatic heart disease. Clin Exp Immunol (2010) 0.78
Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugs. Clin Exp Rheumatol (1998) 0.78
Polymorphisms at the GLUT2 (beta-cell/liver) glucose transporter gene and non-insulin-dependent diabetes mellitus (NIDDM): analysis in affected pedigree members. Clin Genet (1992) 0.78
Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis: report of two cases. Clin Rheumatol (1989) 0.78
[Nailfold capillaroscopy]. Z Rheumatol (2014) 0.78
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study) Eur J Endocrinol (1997) 0.77
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. Nutr Metab Cardiovasc Dis (2010) 0.77
[Occupational therapy in rheumatoid arthritis: short term prospective study in patients treated with anti-TNF-alpha drugs]. Reumatismo (2006) 0.77
Natural killer cells and gamma/delta T cells in synovial fluid and in peripheral blood of patients with psoriatic arthritis. Clin Exp Rheumatol (2004) 0.77
Anterior optic pathways gliomas. The dilemma of treatment. J Neurosurg Sci (1983) 0.77
T cell reactivity to human insulinoma cell line (CM) antigens in patients with type 1 diabetes. Autoimmunity (1999) 0.77
Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA). Clin Exp Rheumatol (2007) 0.77
TSH levels are associated with vitamin D status and seasonality in an adult population of euthyroid adults. Clin Exp Med (2014) 0.77
Nedd5, a novel autoantigen in systemic sclerosis: is it a marker of more severe disease? Ann Rheum Dis (2010) 0.77
Increase in aqueous humor production following D1 receptors activation by means of ibopamine. Int Ophthalmol (1997) 0.76
Dopamine, dopaminergic drugs and ocular hypertension. Int Ophthalmol (1992) 0.76
Rheumatoid nodules and cyclosporin A treatment. Int J Clin Pharmacol Res (1994) 0.76
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Reumatismo (2015) 0.76
Soluble interleukin-2 receptor in Sjögren's syndrome: relation to main serum immunological and immunohistochemical parameters. Clin Rheumatol (2001) 0.76
Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis. Clin Rheumatol (1998) 0.76
Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia (1995) 0.76
Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus. Lupus (2000) 0.76
Establishment of T cell lines to bovine beta-casein and beta-casein-derived epitopes in patients with type 1 diabetes. J Endocrinol (2003) 0.76
Severe anaphylaxis to sheep's milk cheese in a child desensitized to cow's milk through specific oral tolerance induction. Eur Ann Allergy Clin Immunol (2013) 0.76
Multiple cervical cord compressions in psoriatic arthritis. Clin Rheumatol (1992) 0.75
Ultrasound measurements at the proximal phalanges in male patients with psoriatic arthritis. Osteoporos Int (2001) 0.75
[The role of interleukin-12 in immune-mediated rheumatic diseases]. Reumatismo (2002) 0.75
Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis. Ann Rheum Dis (2005) 0.75
Case definition of psoriatic arthritis. Lancet (2000) 0.75
Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes. Clin Exp Immunol (2001) 0.75
[Effect of acetazolamide on Menière's disease]. Acta Otorhinolaryngol Ital (1990) 0.75
[Soluble P-selectin levels in synovial fluid and serum from patients with psoriatic arthritis]. Reumatismo (2005) 0.75
[Treatment of Wegener's granulomatosis]. Reumatismo (2004) 0.75
Evaluation of near-refraction after administration of ibopamine 2%. Acta Ophthalmol Scand Suppl (2000) 0.75
Imaging evidence of successful multiple immunosuppressive treatment of cerebral involvement in Wegener's granulomatosis. Clin Exp Rheumatol (2002) 0.75
[Hospital of St. Mary and of Saint Gallicano in the Trastavere]. Bull Soc Fr Hist Hop (1996) 0.75
[Role for familial and genetic features in the therapeutic response of psoriatic arthritis]. Reumatismo (2004) 0.75
Phenotypic profile of major synovial cell populations in longstanding psoriatic arthritis. J Rheumatol (1987) 0.75
Unusual localisation of an ectopic pregnancy. Clin Exp Obstet Gynecol (1998) 0.75
Changes of glycosylation of serum proteins in Sjögren's syndrome: correlation with interleukin-6 and soluble interleukin-2 receptor. IUBMB Life (1999) 0.75
[Colonic tubular adenoma following ureterosigmoidostomy: CT features]. J Radiol (1999) 0.75
A retrospective study on the effects of laser trabeculoplasty in open-angle glaucoma: a 10-year follow-up. Acta Ophthalmol Scand Suppl (2000) 0.75
Antibodies to bovine beta-casein in diabetes and other autoimmune diseases. Horm Metab Res (2002) 0.75
Changes of glycosylation of serum proteins in psoriatic arthritis, studied by enzyme-linked lectin assay (ELLA), using concanavalin A. Biochem Mol Biol Int (1998) 0.75
The "Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes": Study protocol. Nutr Metab Cardiovasc Dis (2015) 0.75